Capital Investment Advisory Services, LLC Nektar Therapeutics Transaction History

Capital Investment Advisory Services, LLC

  • $988 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 04, 2020
SELL
$15.87 - $23.12 $12,696 - $18,496
-800 Closed
0 $0
Q3 2019

Oct 17, 2019
SELL
$16.91 - $36.27 $3,382 - $7,254
-200 Reduced 20.0%
800 $15,000
Q2 2019

Aug 08, 2019
BUY
$31.0 - $36.3 $29,140 - $34,122
940 Added 1566.67%
1,000 $32,000
Q1 2019

Apr 23, 2019
BUY
$31.58 - $46.35 $1,894 - $2,781
60 New
60 $2,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email